Phase 2, multicenter, open-label basket trial of nab -sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (PRECIS... von Iyer, Gopa, Demeure, Michael J., Deming, Dustin A., Federman, Noah, McKean, Meredith, Lee, Elizabeth Katherine, Spira, Alexander I., Kwiatkowski, David J., Hussein, Maen A., Gordon, Erlinda Maria, Crockett, David G., Ganjoo, Kristen N., Schulte, Brian, Cranmer, Lee D., Schmid, Anita N., Navarro, Willis H., Itri, Loretta Marie

Volltext

Phase 2, multicenter, open-label basket trial of nab-sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (PRECISI... von Deming, Dustin A., Rodon Ahnert, Jordi, Demeure, Michael J., Federman, Noah, McKean, Meredith, Lee, Elizabeth Katherine, Spira, Alexander I., Kwiatkowski, David J., Hussein, Maen A., Gordon, Erlinda Maria, Crockett, David G., Ganjoo, Kristen N., Schulte, Brian, Cranmer, Lee D., Schmid, Anita N., Navarro, Willis H., Itri, Loretta Marie, Iyer, Gopa

Volltext

13- Cis-retinoic acid: Pharmacology, toxicology, and clinical applications for the prevention and treatment of human cancer von Meyskens, Frank L., Goodman, Gary E., Alberts, David S., Itri, Loretta Marie

Volltext